Literature DB >> 12440991

Intracellular ribozyme applications.

D Castanotto1, J R Li, A Michienzi, M-A Langlois, N S Lee, J Puymirat, J J Rossi.   

Abstract

The exquisite target selectivity of trans -acting ribozymes has fostered their use as potential therapeutic agents and tools for down-regulating cellular transcripts. In living cells, free diffusion of RNAs is extremely limited, if it exists at all. Thus, getting ribozymes to base-pair with their cognate targets requires co-localizing the ribozyme transcript with the target RNA. In addition, not all sites along a given target RNA are equally accessible to ribozyme base pairing. Cellular proteins greatly influence the trafficking and structure of RNA, and therefore making ribozymes work effectively in cells a significant challenge. This article addresses the problems of getting engineered ribozymes to effectively pair with and cleave targets in cells. The work described here illuminates methods for target-site selection on native mRNAs, methods for ribozyme expression, and strategies for obtaining a discrete intracellular localization of ribozymes.

Mesh:

Substances:

Year:  2002        PMID: 12440991     DOI: 10.1042/bst0301140

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  6 in total

1.  Synthesis of ribozyme against vascular endothelial growth factor165 and its biological activity in vitro.

Authors:  Zhong-Ping Gu; Yun-Jie Wang; Yu Wu; Jin-Ge Li; Nong-An Chen
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

2.  The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation.

Authors:  Jian Li; Michael Stouffs; Lena Serrander; Botond Banfi; Esther Bettiol; Yves Charnay; Klaus Steger; Karl-Heinz Krause; Marisa E Jaconi
Journal:  Mol Biol Cell       Date:  2006-06-14       Impact factor: 4.138

Review 3.  Novel translational strategies in colorectal cancer research.

Authors:  Ignacio Gil-Bazo
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

4.  A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing.

Authors:  Masatora Fukuda; Kei Kurihara; Yasuyoshi Tanaka; Masanobu Deshimaru
Journal:  RNA       Date:  2012-07-13       Impact factor: 4.942

5.  Trans-cleaving hammerhead ribozymes with tertiary stabilizing motifs: in vitro and in vivo activity against a structured viroid RNA.

Authors:  Alberto Carbonell; Ricardo Flores; Selma Gago
Journal:  Nucleic Acids Res       Date:  2010-11-21       Impact factor: 16.971

6.  Variables and strategies in development of therapeutic post-transcriptional gene silencing agents.

Authors:  Jack M Sullivan; Edwin H Yau; Tiffany A Kolniak; Lowell G Sheflin; R Thomas Taggart; Heba E Abdelmaksoud
Journal:  J Ophthalmol       Date:  2011-06-30       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.